Cargando…
Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar
BACKGROUND: Mass drug administration (MDA) appears to be effective in reducing the risk of malaria parasitaemia. This study reports on programmatic coverage and compliance of MDA using artemisinin-based combination therapy (ACT) in four shehias (smallest administration unit) that had been identified...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557321/ https://www.ncbi.nlm.nih.gov/pubmed/28807035 http://dx.doi.org/10.1186/s12936-017-1982-x |
_version_ | 1783257192382595072 |
---|---|
author | Ali, Abdullah S. Thawer, Narjis G. Khatib, Bakar Amier, Haji H. Shija, Joseph Msellem, Mwinyi Al-mafazy, Abdul-wahid Garimo, Issa A. Mkali, Humphrey Ramsan, Mahdi M. Kafuko, Jessica M. Paxton, Lynn A. Reithinger, Richard Ngondi, Jeremiah M. |
author_facet | Ali, Abdullah S. Thawer, Narjis G. Khatib, Bakar Amier, Haji H. Shija, Joseph Msellem, Mwinyi Al-mafazy, Abdul-wahid Garimo, Issa A. Mkali, Humphrey Ramsan, Mahdi M. Kafuko, Jessica M. Paxton, Lynn A. Reithinger, Richard Ngondi, Jeremiah M. |
author_sort | Ali, Abdullah S. |
collection | PubMed |
description | BACKGROUND: Mass drug administration (MDA) appears to be effective in reducing the risk of malaria parasitaemia. This study reports on programmatic coverage and compliance of MDA using artemisinin-based combination therapy (ACT) in four shehias (smallest administration unit) that had been identified as hotspots through Zanzibar’s malaria case notification surveillance system. METHODS: Mass drug administration was done in four shehias selected on the basis of: being an established malaria hot spot; having had mass screening and treatment (MSaT) 2–6 weeks previously; and exceeding the epidemic alert threshold of 5 cases within a week even after MSaT. Communities were sensitized and MDA was conducted using a house-to-house approach. All household members, except pregnant women and children aged less than 2 months, were provided with ACT medicine. Two weeks after the MDA campaign, a survey was undertaken to investigate completion of ACT doses. RESULTS: A total of 8816 [97.1% of eligible; 95% confidence interval (CI) 96.8–97.5] people received ACT. During post MDA surveys, 2009 people were interviewed: 90.2% reported having completed MDA doses; 1.9% started treatment but did not complete dosage; 4.7% did not take treatment; 2.0% were absent during MDA and 1.2% were ineligible (i.e. infants <2 months and pregnant women). Main reasons for failure to complete treatment were experience of side-effects and forgetting to take subsequent doses. Failure to take treatment was mainly due to fear of side-effects, reluctance due to lack of malaria symptoms and caregivers forgetting to give medication to children. CONCLUSION: Mass drug administration for malaria was well accepted by communities at high risk of malaria in Zanzibar, with high participation and completion rates. Further work to investigate the potential of MDA in accelerating Zanzibar’s efforts towards malaria elimination should be pursued. |
format | Online Article Text |
id | pubmed-5557321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55573212017-08-16 Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar Ali, Abdullah S. Thawer, Narjis G. Khatib, Bakar Amier, Haji H. Shija, Joseph Msellem, Mwinyi Al-mafazy, Abdul-wahid Garimo, Issa A. Mkali, Humphrey Ramsan, Mahdi M. Kafuko, Jessica M. Paxton, Lynn A. Reithinger, Richard Ngondi, Jeremiah M. Malar J Research BACKGROUND: Mass drug administration (MDA) appears to be effective in reducing the risk of malaria parasitaemia. This study reports on programmatic coverage and compliance of MDA using artemisinin-based combination therapy (ACT) in four shehias (smallest administration unit) that had been identified as hotspots through Zanzibar’s malaria case notification surveillance system. METHODS: Mass drug administration was done in four shehias selected on the basis of: being an established malaria hot spot; having had mass screening and treatment (MSaT) 2–6 weeks previously; and exceeding the epidemic alert threshold of 5 cases within a week even after MSaT. Communities were sensitized and MDA was conducted using a house-to-house approach. All household members, except pregnant women and children aged less than 2 months, were provided with ACT medicine. Two weeks after the MDA campaign, a survey was undertaken to investigate completion of ACT doses. RESULTS: A total of 8816 [97.1% of eligible; 95% confidence interval (CI) 96.8–97.5] people received ACT. During post MDA surveys, 2009 people were interviewed: 90.2% reported having completed MDA doses; 1.9% started treatment but did not complete dosage; 4.7% did not take treatment; 2.0% were absent during MDA and 1.2% were ineligible (i.e. infants <2 months and pregnant women). Main reasons for failure to complete treatment were experience of side-effects and forgetting to take subsequent doses. Failure to take treatment was mainly due to fear of side-effects, reluctance due to lack of malaria symptoms and caregivers forgetting to give medication to children. CONCLUSION: Mass drug administration for malaria was well accepted by communities at high risk of malaria in Zanzibar, with high participation and completion rates. Further work to investigate the potential of MDA in accelerating Zanzibar’s efforts towards malaria elimination should be pursued. BioMed Central 2017-08-14 /pmc/articles/PMC5557321/ /pubmed/28807035 http://dx.doi.org/10.1186/s12936-017-1982-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ali, Abdullah S. Thawer, Narjis G. Khatib, Bakar Amier, Haji H. Shija, Joseph Msellem, Mwinyi Al-mafazy, Abdul-wahid Garimo, Issa A. Mkali, Humphrey Ramsan, Mahdi M. Kafuko, Jessica M. Paxton, Lynn A. Reithinger, Richard Ngondi, Jeremiah M. Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar |
title | Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar |
title_full | Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar |
title_fullStr | Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar |
title_full_unstemmed | Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar |
title_short | Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar |
title_sort | artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in zanzibar |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557321/ https://www.ncbi.nlm.nih.gov/pubmed/28807035 http://dx.doi.org/10.1186/s12936-017-1982-x |
work_keys_str_mv | AT aliabdullahs artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT thawernarjisg artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT khatibbakar artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT amierhajih artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT shijajoseph artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT msellemmwinyi artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT almafazyabdulwahid artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT garimoissaa artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT mkalihumphrey artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT ramsanmahdim artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT kafukojessicam artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT paxtonlynna artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT reithingerrichard artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar AT ngondijeremiahm artemisinincombinationtherapymassdrugadministrationinasettingoflowmalariaendemicityprogrammaticcoverageandadherenceduringanobservationalstudyinzanzibar |